20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
Ref.: C.L.20.2020
The Director-General of the World Health Organization presents his compliments to
... Member States and Associate Members and has the honour to attach a draft provisional agenda
for the 148th session of the Executive Board to be held from 18 to 26 January 2021. 1
In accordance with Rule 8 of the Rules of Procedure of the Executive Board, any proposal
from a Member State or Associate Member to include an item on the agenda would normally
reach the Director-General not later than 10 weeks before the commencement of the session of
the Executive Board, that is by 9 November 2020. A balance will be sought between the duration
of the session and the number of items proposed on the agenda. Thereafter, the Director-General
will draw up the provisional agenda in consultation with Officers of the Executive Board. The
provisional agenda will be annotated and explain any deferral or exclusion of proposals made.
It will be dispatched to Member States with the letter of convocation eight weeks before
commencement of the session.
The Director-General of the World Health Organization takes this opportunity to renew to
Member States and Associate Members the assurance of his highest consideration.
GENEVA, 19 June 2020
1
Decision EB147(6).
... ENCL.: (1)
EXECUTIVE BOARD EB148/1 (draft)
148th session 19 June 2020
Geneva, 18–26 January 2021
Draft provisional agenda
1. Opening of the session and adoption of the agenda
2. Report by the Director-General
3. Report of the regional committees
4. Report of the Programme, Budget and Administration Committee of the Executive Board
Pillar 1: One billion more people benefitting from universal health coverage
5. Global action on patient safety
6. Political declaration of the third high-level meeting of the General Assembly on the
prevention and control of non-communicable diseases
7. Expanding access to effective treatments for cancer and rare and orphan diseases, including
medicines, vaccines, medical devices, diagnostics, assistive products, cell- and gene-based
therapies and other health technologies; and improving the transparency of markets for
medicines, vaccines, and other health products
8. Global strategy and plan of action on public health, innovation and intellectual property
9. Antimicrobial resistance
10. Substandard and falsified medical products
11. Standardization of medical devices nomenclature
Pillar 2: One billion more people better protected from health emergencies
12. Public health emergencies: preparedness and response
12.1 COVID-19 response
12.2 WHO’s work in health emergencies
12.3 Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and
other benefits
12.4 The public health implications of implementation of the Nagoya Protocol
EB148/1 (draft)
13. Poliomyelitis
13.1 Poliomyelitis eradication
13.2 Polio transition planning and polio post-certification
Pillar 3: One billion more people enjoying better health and well-being
14. Social determinants of health
Pillar 4: More effective and efficient WHO providing better support to countries
15. Budget and finance matters
15.1 Proposed programme budget 2022–2023
15.2 Financing and implementation of the Programme budget 2020–2021
15.3 Scale of assessments
15.4 Amendments to the Financial Regulations and Financial Rules [if any]
16. Geneva buildings renovation strategy
17. Governance matters
17.1 WHO transformation
17.2 WHO reform
• WHO reform: governance
• WHO reform: involvement of non-State actors in WHO’s governing bodies
17.3 Process for the election of the Director-General of the World Health Organization
17.4 Engagement with non-State actors
• Report on the implementation of the Framework of Engagement with Non-State Actors
• Non-State actors in official relations with WHO
17.5 Provisional agenda of the Seventy-fourth World Health Assembly and date and place of
the 149th session of the Executive Board
18. Committees of the Executive Board
18.1 Membership of the Independent Expert Oversight Advisory Committee [if any]
18.2 Foundation committees and selection panels
2
EB148/1 (draft)
19. Staffing matters
19.1 Statement by the representative of the WHO staff associations
19.2 Report of the Ombudsman
19.3 Human resources: annual report
19.4 Amendments to the Staff Regulations and Staff Rules [if any]
19.5 Report of the International Civil Service Commission
20. Report on meetings of expert committees and study groups
• Expert advisory panels and committees and their membership
21. Closure of the session
= = =
3
Saatja: <
[email protected]>
Saadetud: 19.06.2020 19:08
Teema: WHO: C.L.20.2020 (EB148 draft provisional agenda)
Dear Member States of the World Health Organization,Please find attached,
in the six official languages, C.L.20.2020 regarding EB148 draft
provisional agenda.Best regards,Department of Governing BodiesWorld
Health Organization
Saatja:
[email protected] <
[email protected]>
Teema: WHO: C.L.20.2020 Corr.1 (EB148 draft provisional agenda)
Dear Member States of the World Health Organization,
Please find attached, in the six official languages, C.L.20.2020 Corr.1 regarding EB148 draft provisional agenda.
Best regards,
Department of Governing Bodies
World Health Organization